tiprankstipranks
Mannkind Corp. (MNKD)
NASDAQ:MNKD
US Market
MNKD
MannKind
RESEARCH TOOLSreports
Want to see MNKD full AI Analyst Report?

MannKind (MNKD) Stock News & Sentiment

2,072 Followers
MannKind’s Inhaled Nintedanib Trial: Early IPF Study Moves Forward
Premium
Company Announcements
MannKind’s Inhaled Nintedanib Trial: Early IPF Study Moves Forward
13d ago
MNKD
Biotech Bloodbath Drags Health Care Down as MannKind and Soleno Stocks Sink
Premium
Market News
Biotech Bloodbath Drags Health Care Down as MannKind and Soleno Stocks Sink
2M ago
IBB
XBI
Is MNKD a Buy, Before Earnings?
Premium
Pre-Earnings
Is MNKD a Buy, Before Earnings?
2M ago
MNKD
MannKind: Pediatric Expansion, Improved Dosing, and Pipeline Diversification Drive Buy Rating on Afrezza Growth Potential
Premium
Ratings
MannKind: Pediatric Expansion, Improved Dosing, and Pipeline Diversification Drive Buy Rating on Afrezza Growth Potential
3M ago
MNKD
MannKind Targets Newly Diagnosed Youth With Afrezza: What Investors Should Watch
Premium
Company Announcements
MannKind Targets Newly Diagnosed Youth With Afrezza: What Investors Should Watch
3M ago
MNKD
Multiple 2026 Regulatory, Pipeline, and Partnership Catalysts Underscore MannKind’s Underappreciated Growth Potential and Support Reiterated Buy Rating
Premium
Ratings
Multiple 2026 Regulatory, Pipeline, and Partnership Catalysts Underscore MannKind’s Underappreciated Growth Potential and Support Reiterated Buy Rating
4M ago
MNKD
3 ‘Strong Buy’ Stocks to Buy Today,12/24/2025, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Stocks to Buy Today,12/24/2025, According to Top Analysts
4M ago
NOW
ENGN
More MNKD News >

MNKD News on the Web

MannKind’s Inhaled Nintedanib Trial: Early IPF Study Moves Forward
TipRanks News
Neutral
MannKind price target lowered to $8 from $10 at Mizuho
TipRanks News
Bearish
MannKind price target lowered to $6 from $7 at Truist
TipRanks News
Neutral
Theravance Biopharma price target raised to $17 from $14 at B. Riley
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: MannKind (MNKD) and Praxis Precision Medicines (PRAX)
TipRanks News
Bullish
MannKind Corp at Barclays Global Healthcare Conference Transcript
GuruFocus News
Neutral
MannKind Corp (MNKD) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ...
GuruFocus News
Bullish
Q4 2025 MannKind Corp Earnings Call Transcript
GuruFocus News
Neutral

News Score - Last 7 Days

Neutral
MNKD
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.25 articles
News Sentiment
This Week50%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MNKD’s Media Buzz Sentiment?
1 articles about MNKD were published this week. In an average week, 1.25 articles are published.
    What is MNKD’s weekly average amount of articles?
    In an average week, 1.25 articles about MNKD are published.
      What is MNKD’s News Sentiment?
      50% of articles about MNKD were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week